| 000 | 01843 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250518090022.0 | ||
| 264 | 0 | _c20210107 | |
| 008 | 202101s 0 0 eng d | ||
| 022 | _a1099-0461 | ||
| 024 | 7 |
_a10.1002/jbt.22480 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZou, Jifeng | |
| 245 | 0 | 0 |
_aGinsenoside Rg3 suppresses the growth of gemcitabine-resistant pancreatic cancer cells by upregulating lncRNA-CASC2 and activating PTEN signaling. _h[electronic resource] |
| 260 |
_bJournal of biochemical and molecular toxicology _cJun 2020 |
||
| 300 |
_ae22480 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aDeoxycytidine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
| 650 | 0 | 4 |
_aGinsenosides _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 |
_aPTEN Phosphohydrolase _xmetabolism |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aTransfection |
| 650 | 0 | 4 |
_aTumor Burden _xdrug effects |
| 650 | 0 | 4 |
_aTumor Suppressor Proteins _xgenetics |
| 650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 650 | 0 | 4 | _aGemcitabine |
| 700 | 1 | _aSu, Huafang | |
| 700 | 1 | _aZou, Changling | |
| 700 | 1 | _aLiang, Xiaodong | |
| 700 | 1 | _aFei, Zhenghua | |
| 773 | 0 |
_tJournal of biochemical and molecular toxicology _gvol. 34 _gno. 6 _gp. e22480 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jbt.22480 _zAvailable from publisher's website |
| 999 |
_c30679488 _d30679488 |
||